U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07289477) titled 'A Phase I/III Clinical Study to Evaluate NouvNeu001 Injection for Multiple System Atrophy' on Nov. 26.
Brief Summary: This clinical trial is designed to evaluate the safety, tolerability and preliminary efficacy of a single injection of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in patients with Multiple System Atrophy.
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Condition:
Multiple System Atrophy - Parkinsonian Subtype (MSA-P)
Intervention:
BIOLOGICAL: Human Dopaminergic Progenitor Cells
Single injection of Human Dopaminergic Progenitor Cells into the putamen/striatum region of brain.
Recruitment...